The osteoblastic niche in the context of multiple myeloma

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1335|1|45-62

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1335, Iss.1, 2015-01, pp. : 45-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Immunotherapy in Multiple Myeloma

By Kocoglu Mehmet   Badros Ashraf  

Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Development of Novel Immunotherapies for Multiple Myeloma

By Al-Hujaily Ensaf M.   Oldham Robyn A. A.   Hari Parameswaran   Medin Jeffrey A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1506-1506

MDPI

Access to resources Recommend Favorite

Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1335, Iss. 1, 2015-01 ,pp. : 10-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite